Early use of recombinant factor viia improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock; a pilot study

Mauricio Lynn, Igor Jerokhimov, Dory Jewelewicz, Charles Popkin, Edward W. Johnson, Qammar N. Rashid, Margareth Brown, Uri Martinowitz, Stephen M. Cohn

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint Dive into the research topics of 'Early use of recombinant factor viia improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock; a pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences